Sanofi and GSK partner to develop vaccine against COVID-19
Sanofi and GSK will partner to develop an adjuvanted vaccine for COVID-19, using technology from both companies. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. This technology has produced an exact genetic match to proteins found on the surface of the virus, and the DNA sequence encoding this antigen […]
